Join to View Full Profile
9500 Euclid AveCleveland, OH 44195
Phone+1 800-223-2273
Dr. Moore is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of Pennsylvania Health SystemFellowship, Hematology and Medical Oncology, 1996 - 1997
Case Western Reserve University/University Hospitals Cleveland Medical CenterResidency, Internal Medicine, 1993 - 1996
Case Western Reserve University School of MedicineClass of 1993
Certifications & Licensure
CA State Medical License 2003 - Present
OH State Medical License 1999 - 2028
IL State Medical License 2002 - 2020
NY State Medical License 2003 - 2020
MI State Medical License 2002 - 2018
PA State Medical License 1996 - 2006
American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory - Core EMR, Epic Systems Corporation, 2011, 2013-2014, 2016-2017
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2011, 2013-2014, 2016-2017
- CMS Meaningful Use Stage 2 Certification Beacon Oncology 2014 Certified Module, Epic Systems Corporation, 2011, 2013-2014, 2016-2017
Clinical Trials
- S0230 Goserelin in Preventing Ovarian Failure in Women Receiving Chemotherapy for Breast Cancer Start of enrollment: 2003 Oct 01
- S0221 Adjuvant Doxorubicin, Cyclophosphamide, and Paclitaxel in Treating Patients With Breast Cancer
- Fatigue Caused by Chemotherapy in Women Who Have Undergone Surgery for Breast Cancer and in Healthy Volunteers Start of enrollment: 2008 Jul 01
Publications & Presentations
PubMed
- Radiation therapy management in BRCA1/2 carriers diagnosed with early breast cancer: An international cohort study.Carlotta Becherini, Eva Blondeaux, Virginia Delucchi, Luca Visani, Hee Jeong Kim
Radiotherapy and Oncology. 2026-06-01 - Updated Results of the POSITIVE (Pregnancy Outcome and Safety of Interrupting Therapy for Women with Endocrine Responsive Breast Cancer) Trial.Olivia Pagani, Samuel M Niman, Monica Ruggeri, Fedro A Peccatori, Hatem A Azim Jr
Annals of Oncology. 2026-05-28 - Long-term follow-up of S0221, comparing alternative dose-schedules of anthracycline and taxane therapy in early breast cancer.Azka Ali, William E Barlow, Halle C F Moore, Timothy J Hobday, Claudine Isaacs
JNCI Cancer Spectrum. 2026-03-03
Authored Content
- Pondering the RxPONDER StudyDecember 2020
Press Mentions
VIDEO: OlympiA Trial Shows Olaparib’s Benefits for Patients with BRCA Mutations ‘Persist’December 24th, 2024- VIDEO: Risk-Reducing Surgeries Result in ‘Fewer Breast Cancer Events’ for BRCA CarriersDecember 23rd, 2024
- Merck-AstraZeneca Breast Cancer Drug Reduces Risk of Death by 28% in Patients Diagnosed Early, Clinical Trial ShowsDecember 21st, 2024
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
